NCT01663532View on ClinicalTrials.gov

Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia

PHASE3CompletedINTERVENTIONAL
Enrollment

340

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

August 31, 2013

Study Completion Date

September 30, 2013

Conditions
Schizophrenia
Interventions
DRUG

Aripiprazole IM Depot

DRUG

Placebo

Matching Placebo

Trial Locations (49)

10090

Zagreb

11423

Holliswood

19139

Philadelphia

20016

Washington D.C.

29407

Charleston

30308

Atlanta

32810

Orlando

33021

Hollywood

33301

Fort Lauderdale

33308

Fort Lauderdale

33334

Fort Lauderdale

34208

Bradenton

34741

Kissimmee

39232

Flowood

44317

Popovača

45417

Dayton

60169

Hoffman Estates

63118

St Louis

63128

St Louis

63141

St Louis

63304

Saint Charles

70629

Lake Charles

72201

Little Rock

72764

Springdale

75231

Dallas

75243

Dallas

77007

Houston

78731

Austin

78754

Austin

80209

Denver

84106

Salt Lake City

90660

Pico Rivera

90746

Carson

90806

Long Beach

90813

Long Beach

91403

Sherman Oaks

91950

National City

92025

Escondido

92056

Oceanside

92102

San Diego

92123

San Diego

92701

Santa Ana

92805

Anaheim

94612

Oakland

08053

Marlton

LV-5417

Daugavpils

LV-3008

Jelgava

LV-3401

Liepāja

LV-4730

Strenči

Sponsors
All Listed Sponsors
collaborator

H. Lundbeck A/S

INDUSTRY

collaborator

Otsuka America Pharmaceutical

INDUSTRY

lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY